After nearly a decade of struggling to breathe — and losing her sense of taste and smell — award-winning chef Julia Sullivan ...

When planning for your trip, keep possible nasal polyp triggers in mind, including changes in air pressure, exposure to ...

Chronic rhinosinusitis: This is chronic nasal and sinus irritation and inflammation that persists for at least 12 weeks. Nasal polyps: These are noncancerous (benign) soft tissue growths in your nose.

Nasal polyps are noncancerous (benign) growths that develop in the nose. They are seen in about 20% of people who have chronic rhinosinusitis. You may not notice these growths at first.

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

Antrochoanal polyps (ACPs) are benign, solitary lesions that originate from the mucosa of the maxillary sinus and extend into the nasal cavity towards the choana. They can present with unilateral ...

Tiny magnetic bots that are activated by light can clear bacterial infections deep in the sinus cavities, then be expelled by ...

1.60-point superior reduction in nasal polyp size, a primary endpoint (p<0.0001 1) 8.0-point superior improvement in ability to identify different smells, a primary endpoint (p<0.0001 1).

Sanofi and Regeneron's fast-growing immunology drug Dupixent is on course for a third indication in Europe after being recommended for approval as a treatment for people with nasal polyps ...

EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head ...